HRGN
HARVARD APPRATS REG TCH by Harvard Apparatus Regenerative Technology Inc. (HRGN)
$
87About HARVARD APPRATS REG TCH by Harvard Apparatus Regenerative Technology Inc. (HRGN)
Harvard Apparatus Regenerative Technology, Inc. is a biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. It operates through Cellframe technology, engineered to stimulate the body's signaling pathways and natural healing process to regenerate and restore organ function. The company was founded by David Green on May 3, 2012 and is headquartered in Holliston, MA.
Details
Daily high
$1.87
Daily low
$1.87
Price at open
$1.87
52 Week High
$5.90
52 Week Low
$1.80
Market cap
29.8M
Dividend yield
0.00%
Volume
2,000
Avg. volume
654
P/E ratio
-3.53
HARVARD APPRATS REG TCH by Harvard Apparatus Regenerative Technology Inc. News
Details
Daily high
$1.87
Daily low
$1.87
Price at open
$1.87
52 Week High
$5.90
52 Week Low
$1.80
Market cap
29.8M
Dividend yield
0.00%
Volume
2,000
Avg. volume
654
P/E ratio
-3.53